BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28499941)

  • 1. MTUS1, a gene encoding angiotensin-II type 2 (AT2) receptor-interacting proteins, in health and disease, with special emphasis on its role in carcinogenesis.
    Bozgeyik I; Yumrutas O; Bozgeyik E
    Gene; 2017 Aug; 626():54-63. PubMed ID: 28499941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP.
    Di Benedetto M; Bièche I; Deshayes F; Vacher S; Nouet S; Collura V; Seitz I; Louis S; Pineau P; Amsellem-Ouazana D; Couraud PO; Strosberg AD; Stoppa-Lyonnet D; Lidereau R; Nahmias C
    Gene; 2006 Oct; 380(2):127-36. PubMed ID: 16887298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma.
    Ding X; Zhang N; Cai Y; Li S; Zheng C; Jin Y; Yu T; Wang A; Zhou X
    Mol Oncol; 2012 Feb; 6(1):73-80. PubMed ID: 22153618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular ATIP (Angiotensin receptor type 2 interacting protein) expression in mouse development.
    Bundschu K; Schuh K
    Dev Dyn; 2014 May; 243(5):699-711. PubMed ID: 24288149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative disease.
    Zuern C; Krenacs L; Starke S; Heimrich J; Palmetshofer A; Holtmann B; Sendtner M; Fischer T; Galle J; Wanner C; Seibold S
    Int J Oncol; 2012 Apr; 40(4):1079-88. PubMed ID: 22200760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma.
    Zhao T; Ding X; Chang B; Zhou X; Wang A
    BMC Cancer; 2015 Mar; 15():203. PubMed ID: 25885343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of MTUS1 in gastric cancer promotes tumor growth and metastasis.
    Li X; Liu H; Yu T; Dong Z; Tang L; Sun X
    Neoplasma; 2014; 61(2):128-35. PubMed ID: 24299308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma.
    Di Benedetto M; Pineau P; Nouet S; Berhouet S; Seitz I; Louis S; Dejean A; Couraud PO; Strosberg AD; Stoppa-Lyonnet D; Nahmias C
    Mol Cell Endocrinol; 2006 Jun; 252(1-2):207-15. PubMed ID: 16650523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of MTUS1 in human colon tumors.
    Zuern C; Heimrich J; Kaufmann R; Richter KK; Settmacher U; Wanner C; Galle J; Seibold S
    Oncol Rep; 2010 Jan; 23(1):183-9. PubMed ID: 19956880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.
    Rogler A; Hoja S; Giedl J; Ekici AB; Wach S; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R
    BMC Cancer; 2014 Mar; 14():214. PubMed ID: 24650297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1.
    Li JM; Mogi M; Tsukuda K; Tomochika H; Iwanami J; Min LJ; Nahmias C; Iwai M; Horiuchi M
    Mol Endocrinol; 2007 Feb; 21(2):499-511. PubMed ID: 17068200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTUS1 tumor suppressor and its miRNA regulators in fibroadenoma and breast cancer.
    Kara M; Kaplan M; Bozgeyik I; Ozcan O; Celik OI; Bozgeyik E; Yumrutas O
    Gene; 2016 Aug; 587(2):173-7. PubMed ID: 27155522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule associated tumor suppressor 1 interacts with mitofusins to regulate mitochondrial morphology in endothelial cells.
    Wang Y; Huang Y; Liu Y; Li J; Hao Y; Yin P; Liu Z; Chen J; Wang Y; Wang N; Zhang P
    FASEB J; 2018 Aug; 32(8):4504-4518. PubMed ID: 29558204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function and expression of ATIP and its variants in cardiomyoblast cell line H9c2.
    Varghayee N; Krezel MA; Rezmann L; Chow L; Frauman AG; Louis WJ; Louis SN
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):79-91. PubMed ID: 23559668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk.
    Frank B; Bermejo JL; Hemminki K; Sutter C; Wappenschmidt B; Meindl A; Kiechle-Bahat M; Bugert P; Schmutzler RK; Bartram CR; Burwinkel B
    Carcinogenesis; 2007 Jul; 28(7):1442-5. PubMed ID: 17301065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTUS1 silencing promotes E-selectin production through p38 MAPK-dependent CREB ubiquitination in endothelial cells.
    Wang Y; Dai X; Liu Y; Li J; Liu Z; Yin P; Chen J; Wang Y; Wang N; Zhang P
    J Mol Cell Cardiol; 2016 Dec; 101():1-10. PubMed ID: 27789289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ATIPical family of angiotensin II AT2 receptor-interacting proteins.
    Rodrigues-Ferreira S; Nahmias C
    Trends Endocrinol Metab; 2010 Nov; 21(11):684-90. PubMed ID: 20889352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 2 receptor-interacting protein prevents vascular senescence.
    Min LJ; Mogi M; Iwanami J; Jing F; Tsukuda K; Ohshima K; Horiuchi M
    J Am Soc Hypertens; 2012; 6(3):179-84. PubMed ID: 22361387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico analysis of deleterious SNPs of human MTUS1 gene and their impacts on subsequent protein structure and function.
    Rozario LT; Sharker T; Nila TA
    PLoS One; 2021; 16(6):e0252932. PubMed ID: 34125870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.
    Ye H; Pungpravat N; Huang BL; Muzio LL; Mariggiò MA; Chen Z; Wong DT; Zhou X
    Cancer Genet Cytogenet; 2007 Jul; 176(2):100-6. PubMed ID: 17656251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.